首页 > 最新文献

Journal of Korean Breast Cancer Society最新文献

英文 中文
Decrease in Pulse Oximeter Readings Following Injection of Isosulfan Blue Dye 注射异硫丹蓝染料后脉搏血氧计读数下降
Pub Date : 2003-03-01 DOI: 10.4048/JKBCS.2003.6.1.24
Ji Kun Kim, Soon Yong Park, Myung Kook Lim, C. W. Lee, H. Kim, K. Kwun, Soo Jung Lee
Purpose: A sentinel lymph node mapping with blue dye has been well accepted as a common procedure in breast cancer surgery. However, it is well known that blue dye absorbed into the circulation may interfere pulse oximetery reading. The aim of this study was to evaluate the change of pulse oximetery reading by isosulfan blue dye injection during sentinel lymph node mapping. Methods: Thirteen breast cancer patients with normal preoperative cardiopulmonary functions were studied. Four ml of isosulfan blue dye was injected subdermally when the patient became stable after induction of general anesthesia. The pulse oximetery was monitored continuously. Multiple arterial blood gas analyses (ABGA) were performed before dye injection and 10, 30, 40 minutes after dye injection. The results of oxygen saturturation by oximetery (SpO2) and the results of arterial oxygen tension (SaO2) and arterial oxygen saturation (SaO2) by ABGA were compared. Results: The value of both SaO2 and PaO2 measured by ABGA has not been altered by isosulfan dye injection. However SpO2 decreased by isosulfan dye injection. SpO2 decrease started 8.2±1.5 (2∼20) minutes after dye injection and returned to preinjection level by 85.7±5.6 (60∼126) minutes after injection. The lowest vaule of SpO2 was 95.6 ±1.2% (93∼97). Mean duration of SpO2 decrease was 77.5 ±6.2 (40∼117) minutes. The duration of SpO2 decrease was longer in the aged patients, but it was not statistically significant (p=0.3). There was no siginificant difference in duration of SpO2 decrease according to injection site, operation method, and body mass index (BMI). Conclusion: .Isosulfan dye injection using for sentinel lymph node mapping causes no change in true ABGA results but causes a mild reversible decrease in SpO2, It is important to look for other causes when SpO2 decrease is significant and persistent. (Journal of Korean Breast Cancer Society 2003;6:24-28)
目的:前哨淋巴结定位与蓝色染料已被广泛接受为乳腺癌手术的常见程序。然而,众所周知,被血液循环吸收的蓝色染料可能会干扰脉搏血氧计的读数。本研究的目的是评估异硫丹蓝染料注射在前哨淋巴结定位期间脉搏血氧读数的变化。方法:对13例术前心肺功能正常的乳腺癌患者进行分析。全麻诱导后病情稳定后皮下注射异硫丹蓝染料4ml。连续监测脉搏血氧。染色前及染色后10、30、40分钟行动脉血气分析(ABGA)。比较血氧计测定血氧饱和度(SpO2)和ABGA测定动脉血氧张力(SaO2)和动脉血氧饱和度(SaO2)的结果。结果:ABGA法测定的SaO2和PaO2值未受异硫丹染料注射的影响。注射异硫丹染料后,SpO2降低。SpO2在染料注射后8.2±1.5(2 ~ 20)分钟开始下降,在注射后85.7±5.6(60 ~ 126)分钟恢复到注射前水平。SpO2的最低值为95.6±1.2%(93 ~ 97)。SpO2降低的平均持续时间为77.5±6.2(40 ~ 117)分钟。老年患者SpO2下降持续时间更长,但差异无统计学意义(p=0.3)。注射部位、手术方式、体重指数(BMI)不同,SpO2降低持续时间无显著差异。结论:异硫丹染料注射用于前哨淋巴结测图对ABGA的真实结果没有影响,但引起SpO2的轻度可逆下降,当SpO2下降明显且持续时,寻找其他原因是很重要的。(韩国乳腺癌学会杂志2003;6:24-28)
{"title":"Decrease in Pulse Oximeter Readings Following Injection of Isosulfan Blue Dye","authors":"Ji Kun Kim, Soon Yong Park, Myung Kook Lim, C. W. Lee, H. Kim, K. Kwun, Soo Jung Lee","doi":"10.4048/JKBCS.2003.6.1.24","DOIUrl":"https://doi.org/10.4048/JKBCS.2003.6.1.24","url":null,"abstract":"Purpose: A sentinel lymph node mapping with blue dye has been well accepted as a common procedure in breast cancer surgery. However, it is well known that blue dye absorbed into the circulation may interfere pulse oximetery reading. The aim of this study was to evaluate the change of pulse oximetery reading by isosulfan blue dye injection during sentinel lymph node mapping. Methods: Thirteen breast cancer patients with normal preoperative cardiopulmonary functions were studied. Four ml of isosulfan blue dye was injected subdermally when the patient became stable after induction of general anesthesia. The pulse oximetery was monitored continuously. Multiple arterial blood gas analyses (ABGA) were performed before dye injection and 10, 30, 40 minutes after dye injection. The results of oxygen saturturation by oximetery (SpO2) and the results of arterial oxygen tension (SaO2) and arterial oxygen saturation (SaO2) by ABGA were compared. Results: The value of both SaO2 and PaO2 measured by ABGA has not been altered by isosulfan dye injection. However SpO2 decreased by isosulfan dye injection. SpO2 decrease started 8.2±1.5 (2∼20) minutes after dye injection and returned to preinjection level by 85.7±5.6 (60∼126) minutes after injection. The lowest vaule of SpO2 was 95.6 ±1.2% (93∼97). Mean duration of SpO2 decrease was 77.5 ±6.2 (40∼117) minutes. The duration of SpO2 decrease was longer in the aged patients, but it was not statistically significant (p=0.3). There was no siginificant difference in duration of SpO2 decrease according to injection site, operation method, and body mass index (BMI). Conclusion: .Isosulfan dye injection using for sentinel lymph node mapping causes no change in true ABGA results but causes a mild reversible decrease in SpO2, It is important to look for other causes when SpO2 decrease is significant and persistent. (Journal of Korean Breast Cancer Society 2003;6:24-28)","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"247 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2003-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116208302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary Habit and Cancer Related Information Use in Postoperative Breast Cancer Patients 乳腺癌术后患者饮食习惯与癌症相关信息的使用
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.305
M. Do, Sang Sun Lee, P. Jung
한국에서의 유방암 발생은 꾸준히 증가하는 추세로, 2000년도 보건복지부 통계에 의하면 여성암 중 유방암은 위암 다음으로 2위의 발생률을 나타내어 여성 암중 15.3% 를 차지하고 있다.(1) 한국 여성 유방암의 큰 특징 중의 하 나인 30∼40대 폐경 전 여성 환자의 발생률 증가(2)에 따라 암 수술 후의 젊은 환자 또한 증가하고 있다. 이렇게 지속 적으로 증가하고 있는 암 환자에 비해 암 환자의 수술, 치 료 후의 지속적인 건강 관리를 위한 기본적인 연구인 환 자의 영양 상태와 식습관 등에 대한 연구가 부족한 상황 이다. 역학적 연구 외에 암 환자에 대한 연구들을 살펴보면, 환자의 삶의 질 향상을 위한 연구의 일부로서 사회적 지 지 및 심리적인 부담에 대한 연구,(3-6) 암 환자의 간호(7) 와 영양 상태에 대한 연구들(8,9)이 있다. 하지만, 대부분 의 영양 상태에 관련된 연구들은 소화기계암인 위암과 대 장암 및 간암 등에 국한되어 있으며, 이 중 일부 연구들은 입원한 환자들의 영양 상태에 대해 보고하고 있다.(8-10) 하지만, 암의 경우 입원 당시 영양 상태도 중요하지만, 퇴원 후의 지속적인 영양 관리가 더욱 중요하다. 암 환자 에게 있어서 영양 불량 상태는 암의 치료를 방해하며, 사 망률을 증가시키는 원인이 될 수 있다.(11) 또한 암 환자 의 치료에 있어서 좋은 영양 상태의 유지 역시 중요한 치 료의 한 부분으로 인식되고 있다.(12) 암 환자의 75%는 식 욕부진과 비정상적인 대사 항진으로 열량 섭취의 감소와 더불어 에너지 요구의 증가가 일어나며, 조직의 소모 및 유방암 수술 환자의 식습관과 암 관련 정보원 이용
在韩国的乳腺癌发病呈持续增加趋势、保健福利部据统计,2000年为女性癌症中仅次于胃癌,排名第二的是乳腺癌发生率显示了女性癌症中占15.3%。(1)韩国女性乳腺癌的大特征中的我的30 ~ 40岁绝经前女性根据患者的发生率增加(2)癌症手术后的年轻患者也在增加。与这样持续增加的癌症患者相比,对癌症患者手术、治疗后持续健康管理的基本研究——患者的营养状态和饮食习惯等的研究不足。除了流行病学研究外,对癌症患者的研究包括社会支持和心理负担的研究,作为提高患者生活质量的一部分,(3-6)对癌症患者的护理(7)和营养状态的研究(8,9)。,但大多数营养状况有关的研究消化器官癌症、肝癌胃癌和大张局限等,其中一些研究对住院病人的营养状况报告。(8 - 10),但是如果癌症的,住院当时营养状况很重要,但是出院后的持续的营养管理尤为重要。对癌症患者来说,营养不良情况,是癌症治疗的妨碍,所以死亡率增加的原因。(11)也可以在癌症患者的治疗好的营养状况的维持也是重要的血栓病的一部分正在认识到。(12)式骂不振和75%的癌症患者不正常的代谢亢进,随着热量摄入的减少与能源需求的增加,发生组织消耗及乳腺癌手术患者的饮食习惯以及利用与癌症相关的情报
{"title":"Dietary Habit and Cancer Related Information Use in Postoperative Breast Cancer Patients","authors":"M. Do, Sang Sun Lee, P. Jung","doi":"10.4048/JKBCS.2002.5.4.305","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.305","url":null,"abstract":"한국에서의 유방암 발생은 꾸준히 증가하는 추세로, 2000년도 보건복지부 통계에 의하면 여성암 중 유방암은 위암 다음으로 2위의 발생률을 나타내어 여성 암중 15.3% 를 차지하고 있다.(1) 한국 여성 유방암의 큰 특징 중의 하 나인 30∼40대 폐경 전 여성 환자의 발생률 증가(2)에 따라 암 수술 후의 젊은 환자 또한 증가하고 있다. 이렇게 지속 적으로 증가하고 있는 암 환자에 비해 암 환자의 수술, 치 료 후의 지속적인 건강 관리를 위한 기본적인 연구인 환 자의 영양 상태와 식습관 등에 대한 연구가 부족한 상황 이다. 역학적 연구 외에 암 환자에 대한 연구들을 살펴보면, 환자의 삶의 질 향상을 위한 연구의 일부로서 사회적 지 지 및 심리적인 부담에 대한 연구,(3-6) 암 환자의 간호(7) 와 영양 상태에 대한 연구들(8,9)이 있다. 하지만, 대부분 의 영양 상태에 관련된 연구들은 소화기계암인 위암과 대 장암 및 간암 등에 국한되어 있으며, 이 중 일부 연구들은 입원한 환자들의 영양 상태에 대해 보고하고 있다.(8-10) 하지만, 암의 경우 입원 당시 영양 상태도 중요하지만, 퇴원 후의 지속적인 영양 관리가 더욱 중요하다. 암 환자 에게 있어서 영양 불량 상태는 암의 치료를 방해하며, 사 망률을 증가시키는 원인이 될 수 있다.(11) 또한 암 환자 의 치료에 있어서 좋은 영양 상태의 유지 역시 중요한 치 료의 한 부분으로 인식되고 있다.(12) 암 환자의 75%는 식 욕부진과 비정상적인 대사 항진으로 열량 섭취의 감소와 더불어 에너지 요구의 증가가 일어나며, 조직의 소모 및 유방암 수술 환자의 식습관과 암 관련 정보원 이용","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117285899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Micrometastasis in Peripheral Blood of Breast Cancer Patients Using RT-PCR Assay: Comparison of MUC1, CK19 and hMMG RT-PCR法检测乳腺癌患者外周血微转移:MUC1、CK19、hMMG的比较
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.298
H. Kang, S. Hong, H. Yoon, S. Ahn
유방암으로 진단을 받은 환자에 대하여 정확한 병기를 결정하는 것은 환자의 수술 후 적절한 치료방침을 결정하 는데 매우 중요하다. 최근 10년간 유방암 환자에 대한 치 료 방침은 주목할 만한 변화가 있었으며, 좀 더 많은 환자 들이 보조 항암요법 치료를 받고 있다. 수술 후 보조치료 를 하게 되는 기준으로서 종양의 크기, 액와림프절 전이 상태, 조직 등급 및 종양표지자 등의 예후인자가 쓰이고 있지만 유방암은 다양한 군으로 이루어져 있기 때문에 어 떤 환자들이 조기에 재발을 하는 지에 대한 좀더 정확한 기준이 필요하다. 유방암은 각 개개의 세포에서 다단계의 유전적인 변이를 거치면서 발생하게 되며, 전이는 신생혈 관 형성 등을 포함한 능동적인 다단계의 과정으로서 암세 포의 주변 간질조직, 림프관, 혈관으로의 국소 침윤, 순환 혈류로의 침투 및 다른 장기로의 이동 등의 과정이 포함 된다.(1) 종양의 크기가 작아도 암세포의 확산이 발견될 수 있고, 수술로 원발 종양을 제거한 후에도 림프계나 순 환 혈류에 암세포가 잔존할 수 있어 보편적인 방법으로는 발견할 수 없는 이들 암세포가 유방암 재발의 원인이라고 생각한다.(2) 이러한 이유로 유방암 환자의 말초혈액에 존 재하는 유방암 세포를 발견하는 것이 환자의 생존을 예측 하는 중요한 예후인자로 부각되고 있으며 이에 따라 보조 치료의 방법을 선택하는 기준과 일차 치료 후 추적조사의 유용한 방법이 될 것으로 생각한다.(3,4) 그러나 혈액표본 에 대한 직접적인 세포검사는 진단적 예민도가 매우 낮으 책임저자:안세현, 서울시 송파구 풍납 2동 388-1 ꂕ 138-736, 울산대학교 의과대학 외과학교실 Tel: 02-3010-3490, Fax: 02-474-9027 E-mail: ahnsh@amc.seoul.kr 접수일:2002년 11월 5일, 게재승인일:2002년 12월 15일 유방암 환자의 말초혈액에서 RT-PCR을 이용한 미세전이의 발견: MUC1, CK19, hMMG의 결과 비교
对于被诊断为乳腺癌的患者,决定正确的并期对患者手术后决定适当的治疗方针非常重要。近10年来,乳腺癌患者的治疗方针有了值得关注的变化,更多的患者正在接受辅助抗癌疗法治疗。术后治疗的标准作为肿瘤的大小、腋窝淋巴结转移状态,组织等级及肿瘤标志者等的,虽然有用于乳腺癌预后因子等多种军组成的,所以有些患者们对早期复发,需要更准确的标准。乳腺癌是各单个的细胞在经过传销的遗传变异,即发生转移,形成的新生血馆等在内的能动性传销的过程,癌症三炮周边癫痫组织、关于淋巴血管组织的局部浸润,移动到循环血流的渗透及其他器官等的过程包括:(1)肿瘤的大小小也可以发现癌细胞的扩散,原肿瘤去除脚做过手术之后淋巴系我循环血流癌细胞可以残存在普遍的方法无法发现这些癌细胞乳腺癌复发的原因。(2)认为这样的理由在乳腺癌病人的말초혈액存在是发现乳腺癌细胞的预测患者的生存的重要预后因子,因此,崛起成为选择的标准和辅助治疗的方法一次治疗后跟踪调查的有用的方法将着想。(3、4)但是对血液标本直接세포검사是诊断灵敏度很低、责任作者:안세현,首尔市松坡区、2洞388 - 1ꂕ138 - 736,蔚山大学学校医科大学外科学教室tel: 02 - 3010 - 3490, fax: 02 - 474 - 24.9027 e - mail:ahnsh@amc.seoul.kr接收日期:2002年11月5日,批准刊登日期:2002年12月15日乳房癌患者末梢血液中利用RT-PCR发现微细转移:MUC1、CK19、hMMG的结果比较
{"title":"Detection of Micrometastasis in Peripheral Blood of Breast Cancer Patients Using RT-PCR Assay: Comparison of MUC1, CK19 and hMMG","authors":"H. Kang, S. Hong, H. Yoon, S. Ahn","doi":"10.4048/JKBCS.2002.5.4.298","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.298","url":null,"abstract":"유방암으로 진단을 받은 환자에 대하여 정확한 병기를 결정하는 것은 환자의 수술 후 적절한 치료방침을 결정하 는데 매우 중요하다. 최근 10년간 유방암 환자에 대한 치 료 방침은 주목할 만한 변화가 있었으며, 좀 더 많은 환자 들이 보조 항암요법 치료를 받고 있다. 수술 후 보조치료 를 하게 되는 기준으로서 종양의 크기, 액와림프절 전이 상태, 조직 등급 및 종양표지자 등의 예후인자가 쓰이고 있지만 유방암은 다양한 군으로 이루어져 있기 때문에 어 떤 환자들이 조기에 재발을 하는 지에 대한 좀더 정확한 기준이 필요하다. 유방암은 각 개개의 세포에서 다단계의 유전적인 변이를 거치면서 발생하게 되며, 전이는 신생혈 관 형성 등을 포함한 능동적인 다단계의 과정으로서 암세 포의 주변 간질조직, 림프관, 혈관으로의 국소 침윤, 순환 혈류로의 침투 및 다른 장기로의 이동 등의 과정이 포함 된다.(1) 종양의 크기가 작아도 암세포의 확산이 발견될 수 있고, 수술로 원발 종양을 제거한 후에도 림프계나 순 환 혈류에 암세포가 잔존할 수 있어 보편적인 방법으로는 발견할 수 없는 이들 암세포가 유방암 재발의 원인이라고 생각한다.(2) 이러한 이유로 유방암 환자의 말초혈액에 존 재하는 유방암 세포를 발견하는 것이 환자의 생존을 예측 하는 중요한 예후인자로 부각되고 있으며 이에 따라 보조 치료의 방법을 선택하는 기준과 일차 치료 후 추적조사의 유용한 방법이 될 것으로 생각한다.(3,4) 그러나 혈액표본 에 대한 직접적인 세포검사는 진단적 예민도가 매우 낮으 책임저자:안세현, 서울시 송파구 풍납 2동 388-1 ꂕ 138-736, 울산대학교 의과대학 외과학교실 Tel: 02-3010-3490, Fax: 02-474-9027 E-mail: ahnsh@amc.seoul.kr 접수일:2002년 11월 5일, 게재승인일:2002년 12월 15일 유방암 환자의 말초혈액에서 RT-PCR을 이용한 미세전이의 발견: MUC1, CK19, hMMG의 결과 비교","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133891404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aromtase Inhibitors in Breast Cancer 芳香酶抑制剂在乳腺癌中的作用
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.323
Woo-Shin Shim
Breast cancer is now the second most cancer in women after stomach cancer in Korea, and is increasing continuously. In the year 2000, the crude incidence of breast cancer in Korea was estimated about 23 per 100,000 people.(1) For the process of inducing breast cancer, estrogens appear to play a predominant role. These sex steroids are believed to initiate and to promote the process of the breast carcinogenesis by enhancing the rate of cell division and reducing time available for DNA repair. A new concept is that estrogens can be metabolized to catechol-estrogens and then to quinines that directly damage DNA. These two process-estrogen receptor mediated, genomic effects on proliferation and receptor independent, genotoxic effects of estrogen metabolites-can act in an additive or synergistic fashion to cause breast cancer.(2) Breast cancers that arise in patients can be divided into hormone dependent and hormone independent subtypes.(3) The role of estrogens as modulators of mitogenesis override the influence of other factors in the hormone dependent subtype. These sex steroids stimulate cell proliferation directly by increasing the rate of transcription of early response genes such as c-myc and indirectly through stimulation of growth factors which are produced largely in response to estrogenic regulation.(4) Based upon the concept that estrogen is the proximate regulator of cell proliferation, two general strategies were developed for treatment of hormone dependent breast cancer: blockade of estrogen receptor (ER) action and inhibition of estradiol biosynthesis. Antiestrogens such as tamoxifen bind to ER and interfere with transcription of estrogen induced genes involved in regulating cell proliferation. Clinical trials showed tamoxifen to be effective in inducing objective tumor regressions and to be associated with minimal side effects and toxicity. The second strategy, blockade of estradiol biosynthesis, was demonstrated to be feasible using the steroidogenesis inhibitor, aminoglutethimide, which produced tumor regressions equivalent to those observed with tamoxifen.(3) However, side effects from aminoglutethimide were considerable and its effects on several steroidogenic enzymes required concomitant use of a glucocorticoid. Consequently, tamoxifen became the preferred, first line endocrine agent with which to treat ER-positive advanced breast cancer. However, the clinical efficacy of aminoglutethimide focused attention upon the need to develop more potent, better tolerated, and more specific inhibitors of estrogen biosynthesis.
在韩国,乳腺癌是仅次于胃癌的第二大女性癌症,而且还在持续增加。2000年,韩国乳腺癌的粗发病率估计约为每10万人中有23人。(1)在诱发乳腺癌的过程中,雌激素似乎起着主导作用。这些性类固醇被认为通过提高细胞分裂的速度和减少DNA修复的时间来启动和促进乳腺癌的发生过程。一个新的概念是,雌激素可以被代谢成儿茶酚雌激素,然后变成奎宁,直接破坏DNA。这两个过程——雌激素受体介导的、对增殖的基因组效应和受体独立的、雌激素代谢物的遗传毒性效应——可以以加和协同的方式导致乳腺癌。(2)患者发生的乳腺癌可分为激素依赖亚型和激素独立亚型。(3)在激素依赖亚型中,雌激素作为有丝分裂的调节剂的作用优于其他因素的影响。这些性类固醇通过增加早期反应基因(如c-myc)的转录率直接刺激细胞增殖,并通过间接刺激主要响应雌激素调节而产生的生长因子来刺激细胞增殖。(4)基于雌激素是细胞增殖的近似调节剂的概念,研究人员开发了两种治疗激素依赖性乳腺癌的一般策略:阻断雌激素受体(ER)的作用和抑制雌二醇的生物合成。抗雌激素如他莫昔芬结合内质网并干扰雌激素诱导基因的转录参与调节细胞增殖。临床试验表明,他莫昔芬在诱导客观肿瘤消退方面是有效的,并且副作用和毒性最小。第二种策略,阻断雌二醇的生物合成,被证明是可行的,使用类固醇生成抑制剂,氨酰乙硫胺,其产生的肿瘤消退与使用他莫昔芬观察到的相同。(3)然而,氨酰乙硫胺的副作用相当大,它对几种类固醇生成酶的影响需要同时使用糖皮质激素。因此,他莫昔芬成为首选的一线内分泌药物,用于治疗er阳性晚期乳腺癌。然而,氨基戊硫胺的临床疗效将注意力集中在需要开发更有效、耐受性更好、更特异性的雌激素生物合成抑制剂上。
{"title":"Aromtase Inhibitors in Breast Cancer","authors":"Woo-Shin Shim","doi":"10.4048/JKBCS.2002.5.4.323","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.323","url":null,"abstract":"Breast cancer is now the second most cancer in women after stomach cancer in Korea, and is increasing continuously. In the year 2000, the crude incidence of breast cancer in Korea was estimated about 23 per 100,000 people.(1) For the process of inducing breast cancer, estrogens appear to play a predominant role. These sex steroids are believed to initiate and to promote the process of the breast carcinogenesis by enhancing the rate of cell division and reducing time available for DNA repair. A new concept is that estrogens can be metabolized to catechol-estrogens and then to quinines that directly damage DNA. These two process-estrogen receptor mediated, genomic effects on proliferation and receptor independent, genotoxic effects of estrogen metabolites-can act in an additive or synergistic fashion to cause breast cancer.(2) Breast cancers that arise in patients can be divided into hormone dependent and hormone independent subtypes.(3) The role of estrogens as modulators of mitogenesis override the influence of other factors in the hormone dependent subtype. These sex steroids stimulate cell proliferation directly by increasing the rate of transcription of early response genes such as c-myc and indirectly through stimulation of growth factors which are produced largely in response to estrogenic regulation.(4) Based upon the concept that estrogen is the proximate regulator of cell proliferation, two general strategies were developed for treatment of hormone dependent breast cancer: blockade of estrogen receptor (ER) action and inhibition of estradiol biosynthesis. Antiestrogens such as tamoxifen bind to ER and interfere with transcription of estrogen induced genes involved in regulating cell proliferation. Clinical trials showed tamoxifen to be effective in inducing objective tumor regressions and to be associated with minimal side effects and toxicity. The second strategy, blockade of estradiol biosynthesis, was demonstrated to be feasible using the steroidogenesis inhibitor, aminoglutethimide, which produced tumor regressions equivalent to those observed with tamoxifen.(3) However, side effects from aminoglutethimide were considerable and its effects on several steroidogenic enzymes required concomitant use of a glucocorticoid. Consequently, tamoxifen became the preferred, first line endocrine agent with which to treat ER-positive advanced breast cancer. However, the clinical efficacy of aminoglutethimide focused attention upon the need to develop more potent, better tolerated, and more specific inhibitors of estrogen biosynthesis.","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116719881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Growth and Metastasis of MCF-7 Breast Cancer Cells Grafted to huPBMC-SCID Mouse MCF-7乳腺癌细胞移植到hupmc - scid小鼠的生长和转移
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.273
Sung Hwan Park, D. Choi, Kihyuk Park, D. Joo, H. Lee, Y. Yoo, K. Park, In Soo Suh
암 연구에서 인체 실험은 가장 이상적인 결과를 얻을 수 있는 수단이다. 그러나 인체 실험은 적지 않은 윤리적 및 기술적인 어려움으로 인하여 극히 제한적으로만 가능 할 뿐이다. 따라서 인체 내의 여러가지 조건들과 유사한 환경을 제공할 수 있는 우수한 동물 모델의 개발은 인체 실험에서 나타날 수 있는 위험을 줄이고, 암 발생의 생물 학적인 과정을 밝히며, 새로운 치료법의 개발에 따른 노 력과 비용을 최소화시킬 수 있는 꼭 필요한 방법이다. 그 중에서도 쥐 모델은 암 연구에서 대체하기 어려울 만큼 광범위하게 사용되고 있다. 특히 1962년 흉선이 없는 nude mouse에서 활성화된 T-림프구의 결핍으로 인한 면역 거부 반응의 약화가 알려진 후, nude mouse에 인간의 암 세포나 조직을 이식한 암 연구가 활기를 띠게 되었다. 또한 최근 severe combined immunodeficient (SCID) mouse와 transgenic mouse가 실험에 사용되기 시작한 후에는 한층 더 인체에 가까운 조건에서 쥐 모델을 이용한 세밀하고 구체적인 암 연구가 가능해졌다. SCID mouse는 1983년 Bosma 등(1)이 처음 발견하여 보고하였는데, 이는 생쥐 16번 염색체의 SCID locus에 위치하는 두 대립유전자(allele)들이 유전자 돌연변이 때문에 비활성화되면서 해당 DNA 복구효소 (repair enzyme)의 생성 결핍이 나타나고, 그로 인한 B 및 T 림프구 분화 과정의 V-D-J 유전자(gene)들의 재조합 장 애 때문에 초래된 것이다.(2-4) 따라서 SCID mouse의 림프 구들은 면역 활성이 없는 pro-B cell 및 미숙가슴샘세포 (immature thymocyte) 상태로 남게 되며, 성숙한 B 및 T 림 프구가 결핍된 SCID mouse는 동종은 물론 이종 조직 이 식에도 비교적 약한 거부 반응을 나타나기 때문에 암을 비롯한 선천성 및 후천성 면역결핍증, 감염, 장기 이식 및 human cancers including breast cancer. (Journal of Korean Breast Cancer Society 2002;5:273-278) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
在癌症研究中,人体实验是获得最理想结果的手段。但是,由于不少伦理和技术上的困难,人体实验只能在极有限的范围内进行。因此,人体内的各种条件和类似的环境可以提供优秀的动物模型的开发,在人体试验中可能出现的风险,减少癌症发生的生物科学过程表明,开发新的治疗方法带来的卢历史和费用至少也使必要的方法。其中,老鼠模型在癌症研究中被广泛使用,难以替代。1962年,随着T-淋巴球在无胸腺的nude mouse中活性化,免疫排斥反应减弱的消息被公开,将人类癌细胞或组织移植到nude mouse的癌症研究变得活跃起来。另外,severe combined immunodeficient (SCID) mouse和transgenic mouse最近开始被用于实验后,在更接近人体的条件下,可以利用老鼠模型进行细致而具体的癌症研究。1983年,Bosma等人(1)首次发现并报告了SCID mouse,这是因为位于第16对老鼠染色体SCID locus的两个对立基因(allele)因基因突变而失效,导致DNA修复酶(repair enzyme)缺乏生成。B和T淋巴球分化过程中的V-D-J基因重组障碍(2-4)因此,SCID mouse的淋巴球仍处于没有免疫活性的pro-B cell和未成熟的胸腺细胞(immature thymocyte)状态。缺乏成熟的B和T淋巴结的SCID mouse不仅对同种组织,而且对异种组织的移植也表现出较弱的排斥反应,因此,包括癌症在内的先天性及后天性免疫缺乏症、感染、脏器移植及human cancers including breast cancer。(journal of korean breast cancer society 2002; 5: 273 - 278)ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
{"title":"Growth and Metastasis of MCF-7 Breast Cancer Cells Grafted to huPBMC-SCID Mouse","authors":"Sung Hwan Park, D. Choi, Kihyuk Park, D. Joo, H. Lee, Y. Yoo, K. Park, In Soo Suh","doi":"10.4048/JKBCS.2002.5.4.273","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.273","url":null,"abstract":"암 연구에서 인체 실험은 가장 이상적인 결과를 얻을 수 있는 수단이다. 그러나 인체 실험은 적지 않은 윤리적 및 기술적인 어려움으로 인하여 극히 제한적으로만 가능 할 뿐이다. 따라서 인체 내의 여러가지 조건들과 유사한 환경을 제공할 수 있는 우수한 동물 모델의 개발은 인체 실험에서 나타날 수 있는 위험을 줄이고, 암 발생의 생물 학적인 과정을 밝히며, 새로운 치료법의 개발에 따른 노 력과 비용을 최소화시킬 수 있는 꼭 필요한 방법이다. 그 중에서도 쥐 모델은 암 연구에서 대체하기 어려울 만큼 광범위하게 사용되고 있다. 특히 1962년 흉선이 없는 nude mouse에서 활성화된 T-림프구의 결핍으로 인한 면역 거부 반응의 약화가 알려진 후, nude mouse에 인간의 암 세포나 조직을 이식한 암 연구가 활기를 띠게 되었다. 또한 최근 severe combined immunodeficient (SCID) mouse와 transgenic mouse가 실험에 사용되기 시작한 후에는 한층 더 인체에 가까운 조건에서 쥐 모델을 이용한 세밀하고 구체적인 암 연구가 가능해졌다. SCID mouse는 1983년 Bosma 등(1)이 처음 발견하여 보고하였는데, 이는 생쥐 16번 염색체의 SCID locus에 위치하는 두 대립유전자(allele)들이 유전자 돌연변이 때문에 비활성화되면서 해당 DNA 복구효소 (repair enzyme)의 생성 결핍이 나타나고, 그로 인한 B 및 T 림프구 분화 과정의 V-D-J 유전자(gene)들의 재조합 장 애 때문에 초래된 것이다.(2-4) 따라서 SCID mouse의 림프 구들은 면역 활성이 없는 pro-B cell 및 미숙가슴샘세포 (immature thymocyte) 상태로 남게 되며, 성숙한 B 및 T 림 프구가 결핍된 SCID mouse는 동종은 물론 이종 조직 이 식에도 비교적 약한 거부 반응을 나타나기 때문에 암을 비롯한 선천성 및 후천성 면역결핍증, 감염, 장기 이식 및 human cancers including breast cancer. (Journal of Korean Breast Cancer Society 2002;5:273-278) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115857400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Significance of Hormonal Receptors in Very Young Women with Early Breast Cancer 激素受体在幼年早期乳腺癌患者中的预后意义
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.319
W. Park, K. Sung, Jeong soo Kim, S. Oh, S. Choi, Y. You, H. M. Chun, I. Kim, S. Jung
80.59%, 85.71% (Log rank test, P=0.22) in receptor (+) and (-) group, respectively. Conclusion: Even though the results were not statistically significant, the overall survival of receptor positive group was inferior to that of receptor negative group among the very young premenopausal women with early breast cancer. For the confirmation of the results and better treatment for very young women, a large, prospective case-control study is needed. (Journal of Korean Breast Cancer Society 2002; 5:319-322) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
受体(+)组为80.59%,受体(-)组为85.71% (Log rank检验,P=0.22)。结论:虽然结果无统计学意义,但在非常年轻的绝经前早期乳腺癌患者中,受体阳性组的总生存率低于受体阴性组。为了证实这些结果并为非常年轻的妇女提供更好的治疗,需要进行大规模的前瞻性病例对照研究。(韩国乳腺癌学会杂志2002;5:319 - 322)ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
{"title":"Prognostic Significance of Hormonal Receptors in Very Young Women with Early Breast Cancer","authors":"W. Park, K. Sung, Jeong soo Kim, S. Oh, S. Choi, Y. You, H. M. Chun, I. Kim, S. Jung","doi":"10.4048/JKBCS.2002.5.4.319","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.319","url":null,"abstract":"80.59%, 85.71% (Log rank test, P=0.22) in receptor (+) and (-) group, respectively. Conclusion: Even though the results were not statistically significant, the overall survival of receptor positive group was inferior to that of receptor negative group among the very young premenopausal women with early breast cancer. For the confirmation of the results and better treatment for very young women, a large, prospective case-control study is needed. (Journal of Korean Breast Cancer Society 2002; 5:319-322) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132323387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Effect of Geneticin on the Survival of a Human Breast Cancer Cells under Hypoxic Condition 基因素对缺氧条件下人乳腺癌细胞存活的影响
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.279
Tae-Soon Lee, Sung Hwan Park, Jong Won Lee, S. Lim
Purpose: In solid tumor, there is a region where oxygen supply is insufficient. Under this hypoxic condition, cancer cells became more resistant than normal cells. In this study, we found that one of the aminoglycoside antibiotics, geneticin, made a human breast cancer cell, MCF-7, even more resistant to hypoxia. Methods: On normoxic (21% O2) condition, MCF-7 cells (1.5 ×10 cells/60 mm culture dish) were grown in low glucose (1 g/l) MEM (with 10% FBS) supplemented with 0, 1, 10, 100, and 1000μg/dl geneticin, respectively, for one day. Then, the cells were transferred to hypoxic (1% O2) incubator and grown for 3 days. We examined the viability of cells, the concentration of glucose and lactate and DNA fragmentation assay in each groups. Results: When the cells were grown in low glucose medium under hypoxia (1% O2), all the cells became dead after 2 days of culture in the absence of geneticin whereas the cells still survived even after 3 days of culture in the presence of geneticin (10μg/ml). In the presence of geneticin, the cells survived despite of consumption of all glucose in the medium, whereas the cells became dead once all glucose was consumed in the absence of geneticin. In this case, 저산소 조건에서 제네티신이 유방암세포의 생존에 미치는 영향
目的:在实体瘤中,存在供氧不足的区域。在这种缺氧条件下,癌细胞变得比正常细胞更有抵抗力。在这项研究中,我们发现氨基糖苷类抗生素中的一种,基因素,使人类乳腺癌细胞MCF-7,对缺氧的抵抗力更强。方法:在常氧(21% O2)条件下,MCF-7细胞(1.5 ×10细胞/60 mm培养皿)分别在添加0、1、10、100、1000μg/dl遗传素的低糖(1 g/l) MEM(含10%胎牛血清)中培养1天。然后将细胞转移到低氧(1% O2)培养箱中培养3天。检测各组细胞活力、葡萄糖、乳酸浓度及DNA片段分析。结果:细胞在低氧(1% O2)低糖培养基中培养,在不含遗传素的情况下,培养2天后细胞全部死亡,而在含有遗传素(10μg/ml)的情况下,培养3天后细胞仍存活。在基因素存在的情况下,细胞即使消耗掉培养基中的所有葡萄糖也能存活,而在基因素不存在的情况下,一旦消耗掉所有葡萄糖,细胞就会死亡。在这种情况下,即为“”
{"title":"The Effect of Geneticin on the Survival of a Human Breast Cancer Cells under Hypoxic Condition","authors":"Tae-Soon Lee, Sung Hwan Park, Jong Won Lee, S. Lim","doi":"10.4048/JKBCS.2002.5.4.279","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.279","url":null,"abstract":"Purpose: In solid tumor, there is a region where oxygen supply is insufficient. Under this hypoxic condition, cancer cells became more resistant than normal cells. In this study, we found that one of the aminoglycoside antibiotics, geneticin, made a human breast cancer cell, MCF-7, even more resistant to hypoxia. Methods: On normoxic (21% O2) condition, MCF-7 cells (1.5 ×10 cells/60 mm culture dish) were grown in low glucose (1 g/l) MEM (with 10% FBS) supplemented with 0, 1, 10, 100, and 1000μg/dl geneticin, respectively, for one day. Then, the cells were transferred to hypoxic (1% O2) incubator and grown for 3 days. We examined the viability of cells, the concentration of glucose and lactate and DNA fragmentation assay in each groups. Results: When the cells were grown in low glucose medium under hypoxia (1% O2), all the cells became dead after 2 days of culture in the absence of geneticin whereas the cells still survived even after 3 days of culture in the presence of geneticin (10μg/ml). In the presence of geneticin, the cells survived despite of consumption of all glucose in the medium, whereas the cells became dead once all glucose was consumed in the absence of geneticin. In this case, 저산소 조건에서 제네티신이 유방암세포의 생존에 미치는 영향","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114345276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Significance of the Expression of p27Kip1 Protein in Human Breast Cancer p27Kip1蛋白在人乳腺癌中表达的意义
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.291
C. Kim, K. Yang, Byung-Noe Bae, Ki Hwan Kim, Hongyong Kim, Young Duck Kim, H. Kim, Kyeongmee Park, Sehwan Han
{"title":"Significance of the Expression of p27Kip1 Protein in Human Breast Cancer","authors":"C. Kim, K. Yang, Byung-Noe Bae, Ki Hwan Kim, Hongyong Kim, Young Duck Kim, H. Kim, Kyeongmee Park, Sehwan Han","doi":"10.4048/JKBCS.2002.5.4.291","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.291","url":null,"abstract":"","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121237160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant Chemotherapy for the Local Advanced Breast Cancer 局部晚期乳腺癌的新辅助化疗
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.311
S. Ko, Ilhak Lee, Seung-Ki Kim, Seung-Il Kim, Byeong-Woo Park, Kyong-Sik Lee
후 국소진행성 유방암에서 유도화학요법의 효용성이 여 IIIB, and 16 (13.1%) in IIIC at diagnosis. 10 patients (8.2%) have shown CR, 85 (69.7%) patients PR, and the remaining 27 (22.1%) patients showed NR. The overall response rate to neoadjuvant chemotherapy was 77.5%. However, only 51 (41.8%) were demonstrated to have pathologically downstaged results. There were 32 loco-regional recurrences and 59 distant metastases. All of the initial clinical stage, clinical response to neoadjuvant chemotherapy, and pathologic stage influenced the final outcome of 10 year OS, LRRFS, DRFS. However, in multivariate analysis pathologic stage after neoadjuvant chemotherapy was the most influencing factor on the final outcome. Conclusion: Pathologic stage after neoadjuvant chemotherapy could be the most important prognostic factor of the LABC. (Journal of Korean Breast Cancer Society 2002; 5:311-318)
후국소진행성유방암에서유도화학요법의효용성이여希望,和16(13.1%)在IIIC诊断。CR 10例(8.2%),PR 85例(69.7%),NR 27例(22.1%),新辅助化疗总有效率为77.5%。然而,只有51例(41.8%)被证实有病理降级的结果。32例局部复发,59例远处转移。初始临床阶段、对新辅助化疗的临床反应、病理分期均影响10年OS、LRRFS、DRFS的最终结局。然而,在多因素分析中,新辅助化疗后的病理分期是影响最终结果的最重要因素。结论:新辅助化疗后病理分期是影响LABC预后的重要因素。(韩国乳腺癌学会杂志2002;5:311 - 318)
{"title":"Neoadjuvant Chemotherapy for the Local Advanced Breast Cancer","authors":"S. Ko, Ilhak Lee, Seung-Ki Kim, Seung-Il Kim, Byeong-Woo Park, Kyong-Sik Lee","doi":"10.4048/JKBCS.2002.5.4.311","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.311","url":null,"abstract":"후 국소진행성 유방암에서 유도화학요법의 효용성이 여 IIIB, and 16 (13.1%) in IIIC at diagnosis. 10 patients (8.2%) have shown CR, 85 (69.7%) patients PR, and the remaining 27 (22.1%) patients showed NR. The overall response rate to neoadjuvant chemotherapy was 77.5%. However, only 51 (41.8%) were demonstrated to have pathologically downstaged results. There were 32 loco-regional recurrences and 59 distant metastases. All of the initial clinical stage, clinical response to neoadjuvant chemotherapy, and pathologic stage influenced the final outcome of 10 year OS, LRRFS, DRFS. However, in multivariate analysis pathologic stage after neoadjuvant chemotherapy was the most influencing factor on the final outcome. Conclusion: Pathologic stage after neoadjuvant chemotherapy could be the most important prognostic factor of the LABC. (Journal of Korean Breast Cancer Society 2002; 5:311-318)","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115928925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gene Expression Profiles of Primary Breast Cancer Tissue Using cDNA Microarray 利用cDNA芯片研究原发性乳腺癌组织的基因表达谱
Pub Date : 2002-12-01 DOI: 10.4048/JKBCS.2002.5.4.284
W. Han, K. Chung, Soo‐Jung Ahn, D. Noh, Y. Youn, S. Oh, K. Choe
Purpose: Breast cancer is characterized by an extensive heterogeneity that complicates the precise assessment of tumor aggressiveness and makes therapeutic decisions difficult. Variation in transcriptional programs accounts for much of the biological diversity of the tumors. We tried to investigate the gene expression profile of Korean breast cancer with cDNA microarray technique. Methods: We have characterized variation in gene expression patterns in 7 tissue samples of infiltrating ductal carcinoma from different individuals and 1 tissue sample of malignant phyllodes tumor using cDNA microarray representing 7,500 human genes. Breast cancer cell line, MCF7 and T lymphoblastoid cell line, CCRF-CEM were also included in this study. RNA extracted from normal breast tissue of 3 non-cancer individuals were pooled and used as a control sample. We analyzed the data with Cluster and TreeView program. Results: Tissues from infiltrating ductal carcinoma and tissue from phyllodes tumor and 2 cell lines are clearly differentiated by hierarchical clustering as their pathologic features and showed characteristic genetic expression. Some interesting clusters were found. They were 'stromal cluster', 'immune cluster', 'proliferation and transcription cluster', and a cluster including FOS and JUNB gene. Phylldes tumor showed distinctive genetic expression pattern compared with ductal carcinoma tissues. Two patients whose c-erbB2 protein had been measured as highest level in immunohistochemistry showed overexpression of ERBB2 gene. GRB7, MLN51, and PPARBP in 17q21 that are known to coexpress with ERBB2 also showed overexpression in these patients. Conclusion: We found some interesting clusters and confirmed the feasibility of cDNA microarray in the study of breast cancer. This preliminary study will help the further research of DNA microarray with lager sample size. (Journal of Korean Breast Cancer Society 2002;5:284-290)
目的:乳腺癌的特点是广泛的异质性,使肿瘤侵袭性的精确评估复杂化,使治疗决策变得困难。转录程序的变异在很大程度上解释了肿瘤的生物多样性。我们尝试用cDNA芯片技术研究朝鲜族乳腺癌的基因表达谱。方法:采用包含7500个人类基因的cDNA微阵列技术,对来自不同个体的7例浸润性导管癌组织样本和1例恶性叶状瘤组织样本的基因表达谱进行了分析。乳腺癌细胞系MCF7和T淋巴母细胞样细胞系CCRF-CEM也被纳入本研究。从3名非癌症个体的正常乳腺组织中提取RNA作为对照样本。利用Cluster和TreeView程序对数据进行分析。结果:浸润性导管癌组织和叶状肿瘤组织及2个细胞系的病理特征均有明显的分层聚类分化,并表现出特征性的基因表达。还发现了一些有趣的集群。它们是“基质簇”、“免疫簇”、“增殖和转录簇”以及包含FOS和JUNB基因的簇。与导管癌组织相比,Phylldes肿瘤表现出独特的基因表达模式。免疫组化检测c-erbB2蛋白最高的2例患者出现ERBB2基因过表达。已知与ERBB2共表达的17q21中的GRB7、MLN51和PPARBP在这些患者中也出现过表达。结论:我们发现了一些有趣的簇,证实了cDNA芯片在乳腺癌研究中的可行性。该初步研究将有助于进一步开展大样本DNA微阵列的研究。(韩国乳腺癌学会杂志2002;5:284-290)
{"title":"Gene Expression Profiles of Primary Breast Cancer Tissue Using cDNA Microarray","authors":"W. Han, K. Chung, Soo‐Jung Ahn, D. Noh, Y. Youn, S. Oh, K. Choe","doi":"10.4048/JKBCS.2002.5.4.284","DOIUrl":"https://doi.org/10.4048/JKBCS.2002.5.4.284","url":null,"abstract":"Purpose: Breast cancer is characterized by an extensive heterogeneity that complicates the precise assessment of tumor aggressiveness and makes therapeutic decisions difficult. Variation in transcriptional programs accounts for much of the biological diversity of the tumors. We tried to investigate the gene expression profile of Korean breast cancer with cDNA microarray technique. Methods: We have characterized variation in gene expression patterns in 7 tissue samples of infiltrating ductal carcinoma from different individuals and 1 tissue sample of malignant phyllodes tumor using cDNA microarray representing 7,500 human genes. Breast cancer cell line, MCF7 and T lymphoblastoid cell line, CCRF-CEM were also included in this study. RNA extracted from normal breast tissue of 3 non-cancer individuals were pooled and used as a control sample. We analyzed the data with Cluster and TreeView program. Results: Tissues from infiltrating ductal carcinoma and tissue from phyllodes tumor and 2 cell lines are clearly differentiated by hierarchical clustering as their pathologic features and showed characteristic genetic expression. Some interesting clusters were found. They were 'stromal cluster', 'immune cluster', 'proliferation and transcription cluster', and a cluster including FOS and JUNB gene. Phylldes tumor showed distinctive genetic expression pattern compared with ductal carcinoma tissues. Two patients whose c-erbB2 protein had been measured as highest level in immunohistochemistry showed overexpression of ERBB2 gene. GRB7, MLN51, and PPARBP in 17q21 that are known to coexpress with ERBB2 also showed overexpression in these patients. Conclusion: We found some interesting clusters and confirmed the feasibility of cDNA microarray in the study of breast cancer. This preliminary study will help the further research of DNA microarray with lager sample size. (Journal of Korean Breast Cancer Society 2002;5:284-290)","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121904321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Korean Breast Cancer Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1